Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Protection from chemotherapy-induced neutropenia by ImuVert.

J J Jimenez1, H S Huang, M Hindahl

  • 1Department of Medicine, University of Miami School of Medicine, FL 33101.

The American Journal of the Medical Sciences
|February 1, 1992
PubMed
Summary

ImuVert may mitigate chemotherapy-induced neutropenia by stimulating cytokine production. This study shows ImuVert helps maintain absolute neutrophil counts during Cytoxan and Adriamycin treatment in animal models.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid volumetric rewarming of cryopreserved samples using a steerable ultrasound array.

Ultrasonics·2026
Same author

[Effects of Peroxisome Proliferator-Activated Receptor γ on Modulating Angiopoietin-Like Protein 4 Synthesis in Caco-2 Cells Exposed to Clostridium butyricum].

Molekuliarnaia biologiia·2023
Same author

Monolithic integration of a 10 μm cut-off wavelength InAs/GaSb type-II superlattice diode on GaAs platform.

Scientific reports·2022
Same author

Bioinspired gelatin/bioceramic composites loaded with bone morphogenetic protein-2 (BMP-2) promote osteoporotic bone repair.

Biomaterials advances·2022
Same author

The Mars Environmental Dynamics Analyzer, MEDA. A Suite of Environmental Sensors for the Mars 2020 Mission.

Space science reviews·2021
Same author

[Finite element analysis of the graft stresses after anterior cruciate ligament reconstruction].

Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences·2021

Area of Science:

  • Oncology
  • Immunology
  • Pharmacology

Background:

  • Neutropenia is a significant complication of chemotherapy, increasing patient morbidity.
  • Chemotherapy agents like Cytoxan and Adriamycin can cause severe reductions in neutrophil counts.

Purpose of the Study:

  • To investigate the efficacy of ImuVert in preventing or reducing chemotherapy-induced neutropenia.
  • To assess the impact of ImuVert on absolute neutrophil counts in rats and mice treated with Cytoxan and Adriamycin.

Main Methods:

  • Adult rats and C3H/EJ mice were treated with Cytoxan or Adriamycin, with or without concomitant ImuVert administration.
  • Absolute neutrophil counts were monitored over time in all treatment groups.
  • Endotoxin-hyporesponsive mice were used to further evaluate ImuVert's effects.

Related Experiment Videos

Main Results:

  • In rats, ImuVert treatment maintained significantly higher absolute neutrophil counts during Cytoxan and Adriamycin therapy compared to controls.
  • In mice, ImuVert partially ameliorated the neutropenia induced by Cytoxan, shortening the duration of severe neutropenia.
  • Control groups exhibited profound and prolonged neutropenia following chemotherapy administration.

Conclusions:

  • ImuVert demonstrates a protective effect against chemotherapy-induced neutropenia in preclinical models.
  • The mechanism may involve the stimulation of endogenous cytokine production, supporting bone marrow rescue.
  • ImuVert shows potential as an adjunct therapy to mitigate a major side effect of chemotherapy.